Christy Warich
Director of Investor Relations
Replay available
Fulcrum Therapeutics, Inc. (FULC) Q4 2021 Earnings Call
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q4 2021 earnings conference call, held 2022-03-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Brian Stewart
President and Chief Executive Officer
Judith Dunn
President of R&D
Esther Rangeveld
Chief Financial Officer
Chris Moravito
Chief Medical Officer
Dagon Ha
Stifo
Joseph Schwartz
SBB Securities
Matthew Harrison
Morgan Stanley
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fulcrum Therapeutics, Inc..
Replay transcript excerpt
[Speaker identities could not be resolved; generic labels used] [00:00] Speaker 1: Good morning and welcome to Fulcrum Therapeutics [00:03] Speaker 1: 4th 0.25 and full year 2021 [00:05] Speaker 1: conference call. Currently all participants are in listen only mode. There will be a question and answer session at the end of this call. I would now like to turn the call over to Christy Warrich, Director of Investor Relations at Fulcrum. [00:19] Speaker 1: Please proceed. [00:22] Speaker 2: Thank you, operator. [00:24] Speaker 2: Good morning and welcome to the Fulcrum Therapeutics Conference Call. [00:28] Speaker 2: Please be reminded that remarks made during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. [00:38] Speaker 2: These may include statements about our future expectations and plans, [00:41] Speaker 2: clinical development timeline, and financial projections. [00:45] Speaker 2: While these forward-looking statements represent our views as of today, they should not be relied upon as representing our views in the future. [00:52] Speaker 2: We may update these statements in the future, but we are not taking on an obligation to do so. [00:57] Speaker 2: Please refer to our most recent filings with the Securities and Exchange Commission [01:01] Speaker 2: for discussion of certain risks and uncertainties associated with our business. [01:06] Speaker 2: With me on today's call are Brian Stewart, President and Chief Executive Officer, [01:11] Speaker 2: Judith Dunn, our President of R&D, [01:14] Speaker 2: and Esther Rojavello, our CFO. [01:17] Speaker 2: Chris Morrito, our Chief Medical Officer, and Paul Brunner, our Executive Director of Corporate Development, will also be available for Q&...